These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 4218325)

  • 1. [Effect of pyrazinamide on pH of cytoplasm sections surrounding phagocytized Mycobacteria].
    Pavlov EP; Tushov EG; Koniaev GA
    Probl Tuberk; 1974; (1):77-9. PubMed ID: 4218325
    [No Abstract]   [Full Text] [Related]  

  • 2. Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid.
    Zhang Y; Wade MM; Scorpio A; Zhang H; Sun Z
    J Antimicrob Chemother; 2003 Nov; 52(5):790-5. PubMed ID: 14563891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of antibacterial preparations on growth of Mycobacterium tuberculosis in a model of primary tuberculous infection in tissue culture].
    Kunichan AD; Sokolova GB; Shapatava MN
    Probl Tuberk; 1994; (5):40-3. PubMed ID: 7870726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron enhances the antituberculous activity of pyrazinamide.
    Somoskovi A; Wade MM; Sun Z; Zhang Y
    J Antimicrob Chemother; 2004 Feb; 53(2):192-6. PubMed ID: 14729751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of drug susceptibility of mycobacteria to pyrazinamide in 7H10 agar.
    Stottmeier KD; Beam RE; Kubica GP
    Am Rev Respir Dis; 1967 Nov; 96(5):1072-5. PubMed ID: 4964643
    [No Abstract]   [Full Text] [Related]  

  • 6. [Sensitivity of tubercle bacilli to pyrazinamide determined on the basis of their sensitivity to nicotinamide].
    Tatar J
    Gruzlica; 1974 Aug; 42(8):765-71. PubMed ID: 4277273
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antituberculous activity of pyrazinamide in culture of surviving spleen tissue].
    Pavlov EP
    Probl Tuberk; 1967; 45(2):67-72. PubMed ID: 4974285
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
    Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The paradox of pyrazinamide: an update on the molecular mechanisms of pyrazinamide resistance in Mycobacteria.
    Singh P; Mishra AK; Malonia SK; Chauhan DS; Sharma VD; Venkatesan K; Katoch VM
    J Commun Dis; 2006 Mar; 38(3):288-98. PubMed ID: 17373362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological evaluation of pyrazinamide liposomes for treatment of Mycobacterium tuberculosis.
    El-Ridy MS; Mostafa DM; Shehab A; Nasr EA; Abd El-Alim S
    Int J Pharm; 2007 Feb; 330(1-2):82-8. PubMed ID: 17049192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determining drug resistance of the clinical strains of Mycobacterium tuberculosis to pyrazinamide].
    Nizova AV; Stepanshina VN; Maĭskaia NV; Mironova RI; Bogun AG; Domotenko LV; Morozova TP; Shemiakin IG
    Mol Gen Mikrobiol Virusol; 2008; (4):23-6. PubMed ID: 19172875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of M. tuberculosis in vitro in monocytes and in mice by aminomethylene pyrazinamide analogs.
    Chung WJ; Kornilov A; Brodsky BH; Higgins M; Sanchez T; Heifets LB; Cynamon MH; Welch J
    Tuberculosis (Edinb); 2008 Sep; 88(5):410-9. PubMed ID: 18674969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the pyrazinamidase test for the detection of susceptibility of Mycobacterium tuberculosis to pyrazinamide].
    Montoro Cardoso E; López Novo M; Echemendía Font M; Valdivia Alvarez JA
    Rev Cubana Med Trop; 1999; 51(1):53-4. PubMed ID: 10887557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin and ibuprofen enhance pyrazinamide treatment of murine tuberculosis.
    Byrne ST; Denkin SM; Zhang Y
    J Antimicrob Chemother; 2007 Feb; 59(2):313-6. PubMed ID: 17185297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antitubercular properties of some derivatives of pyrazine carboxylic acid].
    Solov'ev VN; Pavolo EP
    Farmakol Toksikol; 1967; 30(6):734-7. PubMed ID: 4970686
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of pyrazinamide (PZA) as an antitubercular agent].
    Ikeda N
    Kekkaku; 1983 Sep; 58(9):495-8. PubMed ID: 6420603
    [No Abstract]   [Full Text] [Related]  

  • 17. The curious characteristics of pyrazinamide: a review.
    Zhang Y; Mitchison D
    Int J Tuberc Lung Dis; 2003 Jan; 7(1):6-21. PubMed ID: 12701830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutrient-starved incubation conditions enhance pyrazinamide activity against Mycobacterium tuberculosis.
    Huang Q; Chen ZF; Li YY; Zhang Y; Ren Y; Fu Z; Xu SQ
    Chemotherapy; 2007; 53(5):338-43. PubMed ID: 17785970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitrate reductase assay for the rapid detection of pyrazinamide resistance in Mycobacterium tuberculosis using nicotinamide.
    Martin A; Cubillos-Ruiz A; Von Groll A; Del Portillo P; Portaels F; Palomino JC
    J Antimicrob Chemother; 2008 Jan; 61(1):123-7. PubMed ID: 17981833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the BacT/ALERT PZA kit in comparison with the BACTEC 460TB PZA for testing Mycobacterium tuberculosis susceptibility to pyrazinamide.
    Aragón LM; Garrigó M; Moreno C; Español M; Coll P
    J Antimicrob Chemother; 2007 Sep; 60(3):655-7. PubMed ID: 17615155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.